Menu

About Us Industry Report Services Press Release Careers Contact Us

Skin Grafts Market Size, Share, Competitive Landscape, and Trend Analysis Report by Graft Type, Graft Thickness, Applications, Equipment, End user and Region: Global Opportunity Analysis and Industry Forecast, 2024-2032

LI20101079

Pages: 310

Sep 2024

The skin grafts market was valued at $4.92 billion in 2023 and is estimated to reach $9.25 billion by 2033, exhibiting a CAGR of 7.0% from 2024 to 2032.

Market Definition and Overview

Skin grafts are a medical procedure in which skin is transplanted from one area of the body to another. This technique is commonly used to treat extensive wounds, burns, or areas of skin loss due to injury or surgery. The procedure helps to close wounds, reduce the risk of infection, and improve the appearance of the affected area. There are two main types of skin grafts: split-thickness and full-thickness. Split-thickness grafts involve removing the top layers of skin (epidermis and part of the dermis) from a donor site, typically an area that can heal easily such as the thigh or buttocks. These grafts are often used for larger wound areas and heal quickly, but they may not provide the same cosmetic results as full-thickness grafts.

Full-thickness grafts, on the other hand, involve removing all the layers of skin, including the epidermis and entire dermis, from the donor site. These grafts are usually employed for smaller wound areas where a better cosmetic result is desired, such as on the face. However, full-thickness grafts require more meticulous surgical techniques and longer healing times at the donor site.

Key Takeaways

  • The skin grafts market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
  • More than 1,500 product literatures, industry releases, annual reports, and other such documents of major skin grafts industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

Industry Trends

  • In June 2024, Scientists at Stanford University announced a breakthrough in skin graft technology, unveiling a novel method that significantly accelerates wound healing and reduces scarring. Their research, published in the journal Science Translational Medicine, describes the use of genetically modified stem cells to create "supercharged" skin grafts.
  • In March 2024, Smith & Nephew, a global medical technology company, launched PICO 7, the latest version of its single-use Negative Pressure Wound Therapy (NPWT) system, which aids in wound healing, including skin grafts.
  • Mallinckrodt, a global biopharmaceutical company, completed the acquisition of Bioventus' surgical business, which includes products such as EXOGEN® ultrasound bone healing system used in orthopedic procedures, including bone grafts.

Key Market Dynamics

The increasing number of surgical procedures significantly drives the growth of the skin grafts market. Reconstructive surgeries often follow traumatic injuries, cancer treatments, or severe infections, where skin grafts are essential for repairing and restoring damaged skin. The rise in such surgeries, driven by improved surgical techniques and better healthcare access, directly boosts the demand for skin grafts. Cosmetic surgeries, including facelifts, tummy tucks, and body contouring, sometimes require skin grafts to achieve optimal aesthetic outcomes. The increasing societal acceptance of cosmetic procedures, along with advancements in surgical techniques, has led to a rise in the number of these surgeries, thereby increasing the demand for skin grafts.

Skin grafting procedures can be expensive, considering the costs of surgery, hospitalization, post-operative care, and rehabilitation. These high costs can be prohibitive for many patients, especially in low- and middle-income countries, thereby limiting market growth. Skin grafting surgeries carry risks of complications such as graft rejection, infections, scarring, and graft failure. These potential adverse outcomes can deter patients and healthcare providers from opting for skin grafts, thus restraining market growth.

Continued advancements in medical technology, including the development of novel biomaterials, tissue engineering techniques, and 3D printing, present opportunities for innovation in skin grafts. These technological advancements can lead to the creation of more effective and versatile grafting solutions, catering to a broader range of patient needs. The field of regenerative medicine holds promise for revolutionizing skin grafting procedures. Stem cell therapies, growth factors, and tissue engineering approaches offer opportunities to enhance the regenerative capacity of skin grafts, promoting faster wound healing and improved outcomes for patients.

Patents in Global Skin Grafts Market

On December 21, 2023, a patent application was filed by King Abdullah University of Science and Technology with the United States of America office for a novel development in the field of tissue engineering and regenerative medicine. The application details the creation of ultrashort tetrameric peptide nanogels, which have shown significant potential in supporting tissue graft formation, wound healing, and 3D bioprinting.

These newly developed peptide nanogels provide essential native cues to human dermal fibroblasts and mouse myoblast cells, promoting their proliferation and extensive network formation in vitro. This advancement represents a significant improvement in the fabrication of dermal grafts and 3D skin models. Importantly, when applied to full-thickness wounds in a minipig model, the peptide nanogels demonstrated biocompatibility with the minipig skin tissue, as they did not induce wound inflammation. This finding suggests that these peptide nanogels are a safe biomaterial for topical applications.

Additionally, the research highlights the printable nature of these peptides. The successful printing and the high cell viability within the printed constructs pave the way for the 3D bioprinting of various cell types in the future. This capability could revolutionize tissue engineering by enabling the creation of complex tissue structures tailored to individual patient needs.

Market Segmentation

The skin grafts market is segmented into graft type, graft thickness, applications, equipment, end users and region. On the basis of graft type, the market is divided into autologous, isogeneic, allogeneic, xenogeneic, and prosthetic. On the basis of graft thickness, the market is divided into split-thickness, full-thickness, and composite graft. On the basis of applications, the market is divided into extensive wound, burns, extensive skin loss due to infection, skin cancers, and others. On the basis of equipment, the market is divided into dermatome, general surgical instruments, consumables, and others. On the basis of end users, the market is divided into hospitals and clinics, academic and research, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional Market Outlook

The skin grafts market in the Asia-Pacific region is projected to show the fastest growth during the forecast period. The surge in burn incidents within developing nations such as India, Malaysia, and Indonesia is a significant contributor to this trend. The aging population in many Asia-Pacific countries has led to a higher prevalence of chronic wounds, ulcers, and other skin conditions, driving the demand for skin grafting procedures. Increasing disposable income and healthcare spending in countries like China, India, and Southeast Asian nations have facilitated the adoption of advanced medical treatments, including skin grafts. .

Additionally, the skin graft market in China dominated with the largest market share in 2023, while India's skin graft market exhibited the most rapid growth in the Asia-Pacific region.

Competitive Landscape

The major players operating in the skin grafts market include Zimmer Biomet, B. Braun Melsungen AG, Avita Medical, Integra Lifesciences Corporation, Surtex Instruments Limited, Nouvag AG, MiMedx, Organogenesis Inc., De Soutter Medical Limited, and Tissue Regenix.

Recent Key Strategies and Developments

  • In April 2023, Tissue Regenix announced a partnership with a leading healthcare provider to supply its DermaPure® decellularized dermal allograft for use in advanced wound care and reconstructive surgery. This partnership aims to expand the reach of Tissue Regenix’s products in key markets.
  • In December 2021, Kinetic Concepts, Inc. finalized its acquisition of MoMelan Technologies, Inc., a privately owned medical technology company specializing in innovative skin grafting solutions. The terms of the acquisition were not disclosed. MoMelan has pioneered a groundbreaking epidermal grafting solution utilizing donor site-sparing technology, facilitating standardized epidermal skin grafting in office or outpatient settings with minimal discomfort.
  • In February 2023, Integra Lifesciences Corporation announced the expansion of its AmnioExcel® Plus Placental Allograft Membrane, a product designed to enhance wound healing in chronic and acute wounds. This expansion is part of Integra’s strategy to strengthen its position in the regenerative medicine market.

Key Sources Referred

  1. Company Annual Reports
  2. Investor Presentations
  3. Press Releases
  4. Research Papers
  5. D&B Hoovers
  6. ZoomInfo Technologies LLC
  7. National Institutes of Health (NIH) (.gov)
  8. WHO
  9. University Hospitals Coventry & Warwickshire
  10. Centers for Medicare & Medicaid Services | CMS (.gov)

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the skin grafts market segments, current trends, estimations, and dynamics of the skin grafts market analysis from 2024 to 2033 to identify the skin grafts market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the skin grafts market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global skin grafts market statistics.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as skin grafts market trends, key players, market segments, application areas, and market growth strategies.

Aspect

Particulars

Historical Market Estimations

2021-2022

Base Year for Market Estimation

2023

Forecast Timeline for Market Projection

2024-2033

Geographical Scope

North America, Europe, Asia-Pacific, and LAMEA

Segmentation by Graft Type

  • Autologous
  • Isogeneic
  • Allogeneic
  • Xenogeneic
  • Prosthetic

Segmentation by Graft Thickness

  • Split-Thickness
  • Full-Thickness
  • Composite Graft

 

Segmentation by Applications

  • Extensive Wound
  • Burns
  • Extensive Skin Loss Due to Infection
  • Skin Cancers
  • Others

Segmentation by Equipment

  • Dermatome
  • General Surgical Instruments
  • Consumables, and Others

Segmentation by End user

  • Hospitals and Clinics
  • Academic and Research
  • Others

Key Companies Profiled

  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Avita Medical
  • Integra Lifesciences Corporation
  • Surtex Instruments Limited
  • Nouvag AG
  • MiMedx
  • Organogenesis Inc.
  • De Soutter Medical Limited
  • Tissue Regenix.

    1.    Research Methodology

    1.1.    Desk Research
    1.2.    Real time insights and validation
    1.3.    Forecast model
    1.4.    Assumptions and forecast parameters
    1.5.    Market size estimation

    1.5.1.    Top-down approach
    1.5.2.    Bottom-up approach

    2.    Report Scope

    2.1.    Market definition
    2.2.    Key objectives of the study
    2.3.    Report overview
    2.4.    Market segmentation
    2.5.    Overview of the impact of COVID-19 on global Skin Grafts Market    

    3.    Executive Summary
    4.    Market Overview

    4.1.    Introduction
    4.2.    Growth impact forces

    4.2.1.    Drivers
    4.2.2.    Restraints
    4.2.3.    Opportunities

    4.3.    Market value chain analysis

    4.3.1.    List of raw material suppliers
    4.3.2.    List of manufacturers 
    4.3.3.    List of distributors

    4.4.    Innovation & sustainability matrices

    4.4.1.    Technology matrix
    4.4.2.    Regulatory matrix
    4.5.    Porter’s five forces analysis
    4.5.1.    Bargaining power of suppliers
    4.5.2.    Bargaining power of consumers
    4.5.3.    Threat of substitutes
    4.5.4.    Threat of new entrants
    4.5.5.    Competitive rivalry intensity

    4.6.    PESTLE analysis

    4.6.1.    Political
    4.6.2.    Economical
    4.6.3.    Social
    4.6.4.    Technological
    4.6.5.    Legal
    4.6.6.    Environmental

    4.7.    Impact of COVID-19 on Skin Grafts Market    

    4.7.1.    Pre-covid market scenario
    4.7.2.    Post-covid market scenario

    5.    Skin Grafts Market Analysis, by Graft Type 

    5.1.    Overview
    5.2.    Autologous

    5.2.1.    Definition, key trends, growth factors, and opportunities
    5.2.2.    Market size analysis, by region, 2023-2033
    5.2.3.    Market share analysis, by country, 2023-2033

    5.3.    Isogeneic

    5.3.1.    Definition, key trends, growth factors, and opportunities
    5.3.2.    Market size analysis, by region, 2023-2033
    5.3.3.    Market share analysis, by country, 2023-2033

    5.4.    Allogeneic

    5.4.1.    Definition, key trends, growth factors, and opportunities
    5.4.2.    Market size analysis, by region, 2023-2033
    5.4.3.    Market share analysis, by country, 2023-2033

    5.5.    Xenogeneic

    5.5.1.    Definition, key trends, growth factors, and opportunities
    5.5.2.    Market size analysis, by region, 2023-2033
    5.5.3.    Market share analysis, by country, 2023-2033

    5.6.    Prosthetic

    5.6.1.    Definition, key trends, growth factors, and opportunities
    5.6.2.    Market size analysis, by region, 2023-2033
    5.6.3.    Market share analysis, by country, 2023-2033

    5.7.    Research Dive Exclusive Insights

    5.7.1.    Market attractiveness
    5.7.2.    Competition heatmap

    6.    Skin Grafts Market Analysis, by Graft Thickness 

    6.1.    Overview
    6.2.    Split-Thickness   

    6.2.1.    Definition, key trends, growth factors, and opportunities
    6.2.2.    Market size analysis, by region, 2023-2033
    6.2.3.    Market share analysis, by country, 2023-2033

    6.3.    Full-Thickness

    6.3.1.    Definition, key trends, growth factors, and opportunities
    6.3.2.    Market size analysis, by region, 2023-2033
    6.3.3.    Market share analysis, by country, 2023-2033

    6.4.    Composite Graft

    6.4.1.    Definition, key trends, growth factors, and opportunities
    6.4.2.    Market size analysis, by region, 2023-2033
    6.4.3.    Market share analysis, by country, 2023-2033

    6.5.    Research Dive Exclusive Insights

    6.5.1.    Market attractiveness
    6.5.2.    Competition heatmap

    7.    Skin Grafts Market Analysis, by Applications

    7.1.    Overview
    7.2.    Extensive Wound 

    7.2.1.    Definition, key trends, growth factors, and opportunities
    7.2.2.    Market size analysis, by region, 2023-2033
    7.2.3.    Market share analysis, by country, 2023-2033

    7.3.    Burns

    7.3.1.    Definition, key trends, growth factors, and opportunities
    7.3.2.    Market size analysis, by region, 2023-2033
    7.3.3.    Market share analysis, by country, 2023-2033

    7.4.    Extensive Skin Loss Due to Infection

    7.4.1.    Definition, key trends, growth factors, and opportunities
    7.4.2.    Market size analysis, by region, 2023-2033
    7.4.3.    Market share analysis, by country, 2023-2033

    7.5.    Skin Cancers

    7.5.1.    Definition, key trends, growth factors, and opportunities
    7.5.2.    Market size analysis, by region, 2023-2033
    7.5.3.    Market share analysis, by country, 2023-2033

    7.6.    Others

    7.6.1.    Definition, key trends, growth factors, and opportunities
    7.6.2.    Market size analysis, by region, 2023-2033
    7.6.3.    Market share analysis, by country, 2023-2033

    7.7.    Research Dive Exclusive Insights

    7.7.1.    Market attractiveness
    7.7.2.    Competition heatmap

    8.    Skin Grafts Market Analysis, by Equipment

    8.1.    Overview
    8.2.    Dermatome 

    8.2.1.    Definition, key trends, growth factors, and opportunities
    8.2.2.    Market size analysis, by region, 2023-2033
    8.2.3.    Market share analysis, by country, 2023-2033

    8.3.    General Surgical Instruments

    8.3.1.    Definition, key trends, growth factors, and opportunities
    8.3.2.    Market size analysis, by region, 2023-2033
    8.3.3.    Market share analysis, by country, 2023-2033

    8.4.    Consumables

    8.4.1.    Definition, key trends, growth factors, and opportunities
    8.4.2.    Market size analysis, by region, 2023-2033
    8.4.3.    Market share analysis, by country, 2023-2033

    8.5.    Others

    8.5.1.    Definition, key trends, growth factors, and opportunities
    8.5.2.    Market size analysis, by region, 2023-2033
    8.5.3.    Market share analysis, by country, 2023-2033

    8.6.    Research Dive Exclusive Insights

    8.6.1.    Market attractiveness
    8.6.2.    Competition heatmap

    9.    Skin Grafts Market Analysis, by End Users

    9.1.    Overview
    9.2.    Hospitals and Clinics 

    9.2.1.    Definition, key trends, growth factors, and opportunities
    9.2.2.    Market size analysis, by region, 2023-2033
    9.2.3.    Market share analysis, by country, 2023-2033

    9.3.    Academic and Research

    9.3.1.    Definition, key trends, growth factors, and opportunities
    9.3.2.    Market size analysis, by region, 2023-2033
    9.3.3.    Market share analysis, by country, 2023-2033

    9.4.    Others

    9.4.1.    Definition, key trends, growth factors, and opportunities
    9.4.2.    Market size analysis, by region, 2023-2033
    9.4.3.    Market share analysis, by country, 2023-2033

    9.5.    Research Dive Exclusive Insights

    9.5.1.    Market attractiveness
    9.5.2.    Competition heatmap

    10.    Skin Grafts Market, by Region

    10.1.    North America

    10.1.1.    U.S.

    10.1.1.1.    Market size analysis, by Graft Type, 2023-2033
    10.1.1.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.1.1.3.    Market size analysis, by Applications, 2023-2033
    10.1.1.4.    Market size analysis, by Equipment, 2023-2033
    10.1.1.5.    Market size analysis, by End User, 2023-2033

    10.1.2.    Canada

    10.1.2.1.    Market size analysis, by Graft Type, 2023-2033
    10.1.2.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.1.2.3.    Market size analysis, by Applications, 2023-2033
    10.1.2.4.    Market size analysis, by Equipment, 2023-2033
    10.1.2.5.    Market size analysis, by End User, 2023-2033

    10.1.3.    Mexico

    10.1.3.1.    Market size analysis, by Graft Type, 2023-2033
    10.1.3.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.1.3.3.    Market size analysis, by Applications, 2023-2033
    10.1.3.4.    Market size analysis, by Equipment, 2023-2033
    10.1.3.5.    Market size analysis, by End User, 2023-2033

    10.1.4.    Research Dive Exclusive Insights

    10.1.4.1.    Market attractiveness
    10.1.4.2.    Competition heatmap

    10.2.    Europe

    10.2.1.    Germany 

    10.2.1.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.1.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.1.3.    Market size analysis, by Applications, 2023-2033
    10.2.1.4.    Market size analysis, by Equipment, 2023-2033
    10.2.1.5.    Market size analysis, by End User, 2023-2033

    10.2.2.    UK

    10.2.2.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.2.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.2.3.    Market size analysis, by Applications, 2023-2033
    10.2.2.4.    Market size analysis, by Equipment, 2023-2033
    10.2.2.5.    Market size analysis, by End User, 2023-2033

    10.2.3.    France

    10.2.3.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.3.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.3.3.    Market size analysis, by Applications, 2023-2033
    10.2.3.4.    Market size analysis, by Equipment, 2023-2033
    10.2.3.5.    Market size analysis, by End User, 2023-2033

    10.2.4.    Spain

    10.2.4.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.4.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.4.3.    Market size analysis, by Applications, 2023-2033
    10.2.4.4.    Market size analysis, by Equipment, 2023-2033
    10.2.4.5.    Market size analysis, by End User, 2023-2033

    10.2.5.    Italy

    10.2.5.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.5.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.5.3.    Market size analysis, by Applications, 2023-2033
    10.2.5.4.    Market size analysis, by Equipment, 2023-2033
    10.2.5.5.    Market size analysis, by End User, 2023-2033

    10.2.6.    Rest of Europe

    10.2.6.1.    Market size analysis, by Graft Type, 2023-2033
    10.2.6.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.2.6.3.    Market size analysis, by Applications, 2023-2033
    10.2.6.4.    Market size analysis, by Equipment, 2023-2033
    10.2.6.5.    Market size analysis, by End User, 2023-2033

    10.2.7.    Research Dive Exclusive Insights

    10.2.7.1.    Market attractiveness
    10.2.7.2.    Competition heatmap

    10.3.    Asia-Pacific

    10.3.1.    China

    10.3.1.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.1.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.1.3.    Market size analysis, by Applications, 2023-2033
    10.3.1.4.    Market size analysis, by Equipment, 2023-2033
    10.3.1.5.    Market size analysis, by End User, 2023-2033

    10.3.2.    Japan 

    10.3.2.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.2.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.2.3.    Market size analysis, by Applications, 2023-2033
    10.3.2.4.    Market size analysis, by Equipment, 2023-2033
    10.3.2.5.    Market size analysis, by End User, 2023-2033

    10.3.3.    India

    10.3.3.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.3.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.3.3.    Market size analysis, by Applications, 2023-2033
    10.3.3.4.    Market size analysis, by Equipment, 2023-2033
    10.3.3.5.    Market size analysis, by End User, 2023-2033

    10.3.4.    Australia

    10.3.4.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.4.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.4.3.    Market size analysis, by Applications, 2023-2033
    10.3.4.4.    Market size analysis, by Equipment, 2023-2033
    10.3.4.5.    Market size analysis, by End User, 2023-2033

    10.3.5.    South Korea

    10.3.5.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.5.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.5.3.    Market size analysis, by Applications, 2023-2033
    10.3.5.4.    Market size analysis, by Equipment, 2023-2033
    10.3.5.5.    Market size analysis, by End User, 2023-2033

    10.3.6.    Rest of Asia-Pacific

    10.3.6.1.    Market size analysis, by Graft Type, 2023-2033
    10.3.6.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.3.6.3.    Market size analysis, by Applications, 2023-2033
    10.3.6.4.    Market size analysis, by Equipment, 2023-2033
    10.3.6.5.    Market size analysis, by End User, 2023-2033

    10.3.7.    Research Dive Exclusive Insights

    10.3.7.1.    Market attractiveness
    10.3.7.2.    Competition heatmap

    10.4.    LAMEA

    10.4.1.    Brazil

    10.4.1.1.    Market size analysis, by Graft Type, 2023-2033
    10.4.1.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.4.1.3.    Market size analysis, by Applications, 2023-2033
    10.4.1.4.    Market size analysis, by Equipment, 2023-2033
    10.4.1.5.    Market size analysis, by End User, 2023-2033

    10.4.2.    Saudi Arabia

    10.4.2.1.    Market size analysis, by Graft Type, 2023-2033
    10.4.2.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.4.2.3.    Market size analysis, by Applications, 2023-2033
    10.4.2.4.    Market size analysis, by Equipment, 2023-2033
    10.4.2.5.    Market size analysis, by End User, 2023-2033

    10.4.3.    UAE

    10.4.3.1.    Market size analysis, by Graft Type, 2023-2033
    10.4.3.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.4.3.3.    Market size analysis, by Applications, 2023-2033
    10.4.3.4.    Market size analysis, by Equipment, 2023-2033
    10.4.3.5.    Market size analysis, by End User, 2023-2033

    10.4.4.    South Africa

    10.4.4.1.    Market size analysis, by Graft Type, 2023-2033
    10.4.4.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.4.4.3.    Market size analysis, by Applications, 2023-2033
    10.4.4.4.    Market size analysis, by Equipment, 2023-2033
    10.4.4.5.    Market size analysis, by End User, 2023-2033

    10.4.5.    Rest of LAMEA

    10.4.5.1.    Market size analysis, by Graft Type, 2023-2033
    10.4.5.2.    Market size analysis, by Graft Thickness, 2023-2033
    10.4.5.3.    Market size analysis, by Applications, 2023-2033
    10.4.5.4.    Market size analysis, by Equipment, 2023-2033
    10.4.5.5.    Market size analysis, by End User, 2023-2033

    10.4.6.    Research Dive Exclusive Insights

    10.4.6.1.    Market attractiveness
    10.4.6.2.    Competition heatmap

    11.    Competitive Landscape

    11.1.    Top winning strategies, 2022

    11.1.1.    By strategy
    11.1.2.    By year

    11.2.    Strategic overview
    11.3.    Market share analysis, 2023

    12.    Company Profiles

    12.1.    Zimmer Biomet

    12.1.1.    Overview
    12.1.2.    Business segments
    12.1.3.    Product portfolio
    12.1.4.    Financial performance
    12.1.5.    Recent developments
    12.1.6.    SWOT analysis

    12.2.    B. Braun Melsungen AG

    12.2.1.    Overview
    12.2.2.    Business segments
    12.2.3.    Product portfolio
    12.2.4.    Financial performance
    12.2.5.    Recent developments
    12.2.6.    SWOT analysis

    12.3.    Avita Medical

    12.3.1.    Overview
    12.3.2.    Business segments
    12.3.3.    Product portfolio
    12.3.4.    Financial performance
    12.3.5.    Recent developments
    12.3.6.    SWOT analysis

    12.4.    Integra Lifesciences Corporation

    12.4.1.    Overview
    12.4.2.    Business segments
    12.4.3.    Product portfolio
    12.4.4.    Financial performance
    12.4.5.    Recent developments
    12.4.6.    SWOT analysis

    12.5.    Surtex Instruments Limited

    12.5.1.    Overview
    12.5.2.    Business segments
    12.5.3.    Product portfolio
    12.5.4.    Financial performance
    12.5.5.    Recent developments
    12.5.6.    SWOT analysis

    12.6.    Nouvag AG

    12.6.1.    Overview
    12.6.2.    Business segments
    12.6.3.    Product portfolio
    12.6.4.    Financial performance
    12.6.5.    Recent developments
    12.6.6.    SWOT analysis

    12.7.    MiMedx

    12.7.1.    Overview
    12.7.2.    Business segments
    12.7.3.    Product portfolio
    12.7.4.    Financial performance
    12.7.5.    Recent developments
    12.7.6.    SWOT analysis

    12.8.    Organogenesis Inc.

    12.8.1.    Overview
    12.8.2.    Business segments
    12.8.3.    Product portfolio
    12.8.4.    Financial performance
    12.8.5.    Recent developments
    12.8.6.    SWOT analysis

    12.9.    De Soutter Medical Limited

    12.9.1.    Overview
    12.9.2.    Business segments
    12.9.3.    Product portfolio
    12.9.4.    Financial performance
    12.9.5.    Recent developments
    12.9.6.    SWOT analysis

    12.10.    Tissue Regenix

    12.10.1.    Overview
    12.10.2.    Business segments
    12.10.3.    Product portfolio
    12.10.4.    Financial performance
    12.10.5.    Recent developments
    12.10.6.    SWOT analysis

    Purchase Full Report of
    Skin Grafts Market

    PURCHASE OPTIONS

      

    * Taxes/Fees, If applicable will be added during checkout. All prices in USD.

    Have a question ?

    Enquire To Buy

    Need to add more ?

    Request Customization

    Customers Also Viewed